XML 41 R28.htm IDEA: XBRL DOCUMENT v3.25.3
SEGMENT INFORMATION (Tables)
9 Months Ended
Sep. 30, 2025
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
The table below details the Company’s revenues, significant expenses, and other segment items and reconciles those amounts to the Company’s consolidated net loss as computed under U.S. GAAP in the accompanying Condensed Consolidated Statements of Operations:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
Revenues$581 $49,412 $25,324 $50,249 
Less:
Research and development14,020 19,316 43,774 55,398 
General and administrative6,716 11,199 23,498 29,559 
Clinical manufacturing operations13,175 7,075 34,251 27,931 
Impairment of long-lived assets— — — 5,521 
Stock-based compensation2,127 3,315 6,949 9,099 
Other segment items (*)
(527)(2,165)2,365 (2,714)
Net loss$(34,930)$10,672 $(85,513)$(74,545)
(*) Other segment items include restructuring charges, interest income, other income (expense), net, and income tax (benefit) expense.